- Home
- NLSP vs EVM Comparison
NLSP vs EVM Comparison
Compare NLSP & EVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- EVM
- Stock Information
- Founded
- NLSP 2015
- EVM 2002
- Country
- NLSP Switzerland
- EVM United States
- Employees
- NLSP N/A
- EVM N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- EVM Finance/Investors Services
- Sector
- NLSP Health Care
- EVM Finance
- Exchange
- NLSP Nasdaq
- EVM Nasdaq
- Market Cap
- NLSP 12.4M
- EVM 217.4M
- IPO Year
- NLSP 2021
- EVM N/A
- Fundamental
- Price
- NLSP $2.44
- EVM $9.01
- Analyst Decision
- NLSP
- EVM
- Analyst Count
- NLSP 0
- EVM 0
- Target Price
- NLSP N/A
- EVM N/A
- AVG Volume (30 Days)
- NLSP 407.1K
- EVM 55.8K
- Earning Date
- NLSP 07-15-2025
- EVM 01-01-0001
- Dividend Yield
- NLSP N/A
- EVM 4.01%
- EPS Growth
- NLSP N/A
- EVM N/A
- EPS
- NLSP N/A
- EVM 0.20
- Revenue
- NLSP N/A
- EVM N/A
- Revenue This Year
- NLSP N/A
- EVM N/A
- Revenue Next Year
- NLSP N/A
- EVM N/A
- P/E Ratio
- NLSP N/A
- EVM $47.61
- Revenue Growth
- NLSP N/A
- EVM N/A
- 52 Week Low
- NLSP $1.30
- EVM $7.67
- 52 Week High
- NLSP $15.59
- EVM $9.59
- Technical
- Relative Strength Index (RSI)
- NLSP 52.64
- EVM 63.35
- Support Level
- NLSP $2.16
- EVM $8.84
- Resistance Level
- NLSP $3.08
- EVM $8.98
- Average True Range (ATR)
- NLSP 0.24
- EVM 0.08
- MACD
- NLSP -0.00
- EVM 0.03
- Stochastic Oscillator
- NLSP 30.21
- EVM 96.65
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
About EVM Eaton Vance California Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance California Municipal Bond Fund is an investment company with an objective to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in its specified state. The company provides its solutions to individual investors, institutional investors, high net worth individuals, family office investors, and financial professionals. It offers a range of equity, income, and alternative strategies to institutional investors, both in the United States and internationally.